This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics Europe
4 - 6 June, 2024
Excel London Platinum Suite

Sophia Hober, PhD
Professor and Principal Investigator at KTH Royal Institute of Technology


Sophia Hober is Professor of Molecular Biotechnology at KTH in Stockholm, Sweden. She is working with the design and development of detection and purification systems including improvements of the alkaline tolerance of protein A for industrial purification of IgG, leading to a product sold by Cytiva (MabSelect SuRe). Moreover, two novel libraries with different characteristics have been designed based on small scaffold proteins. These are utilized for development of binders for use in protein purification as well as for cancer theranostics. Prof. Hober is the author of more than 190 full‑length scientific papers and has filed more than 20 international patent applications. Prof. Hober is cofounder of 4 start-up companies and member of several Board of Directors. She is also elected member of the Royal Swedish Academy of Engineering Sciences.

Agenda Sessions

  • Development of Protein Domains for Diagnostic and Therapeutic Use